{
     "PMID": "7579146",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19951128",
     "LR": "20141120",
     "IS": "0959-4965 (Print) 0959-4965 (Linking)",
     "VI": "6",
     "IP": "11",
     "DP": "1995 Jul 31",
     "TI": "Benzodiazepine antagonist flumazenil reduces hippocampal epileptiform activity.",
     "PG": "1549-52",
     "AB": "We examined the effects of the benzodiazepine antagonist, flumazenil, on epileptiform discharges evoked in the hippocampal CA1 region in vitro. Application of 100 nM flumazenil did not affect normal synaptic responses; however, flumazenil did depress epileptiform discharges induced by 8 mM [K+]o. Epileptiform discharges induced by the GABAA channel antagonist picrotoxin or by the K+ channel blocker 4-aminopyridine were unaffected. Application of the high-affinity, low-efficacy benzodiazepine partial inverse agonist, Ro 19-4603, blocked the anticonvulsant effect of flumazenil, indicating that this action of flumazenil is mediated at a benzodiazepine binding site located on the GABAA receptor. A likely explanation of the present results is that flumazenil antagonizes the action of an endogenous benzodiazepine inverse agonist, which is released during epileptiform discharges evoked in high K+ ACSF.",
     "FAU": [
          "Polc, P",
          "Jahromi, S S",
          "Facciponte, G",
          "Pelletier, M R",
          "Zhang, L",
          "Carlen, P L"
     ],
     "AU": [
          "Polc P",
          "Jahromi SS",
          "Facciponte G",
          "Pelletier MR",
          "Zhang L",
          "Carlen PL"
     ],
     "AD": "Department of Medicine (Neurology), Playfair Neuroscience Unit, Toronto Hospital Research Institute, Ontario, Canada.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "England",
     "TA": "Neuroreport",
     "JT": "Neuroreport",
     "JID": "9100935",
     "RN": [
          "0 (Anticonvulsants)",
          "0 (GABA Modulators)",
          "0 (GABA-A Receptor Antagonists)",
          "40P7XK9392 (Flumazenil)",
          "RWP5GA015D (Potassium)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Anticonvulsants/*pharmacology",
          "Flumazenil/*pharmacology",
          "GABA Modulators/*pharmacology",
          "*GABA-A Receptor Antagonists",
          "Hippocampus/*drug effects",
          "In Vitro Techniques",
          "Microchemistry",
          "Potassium/pharmacology",
          "Rats",
          "Rats, Wistar",
          "Synapses/drug effects"
     ],
     "EDAT": "1995/07/31 00:00",
     "MHDA": "1995/07/31 00:01",
     "CRDT": [
          "1995/07/31 00:00"
     ],
     "PHST": [
          "1995/07/31 00:00 [pubmed]",
          "1995/07/31 00:01 [medline]",
          "1995/07/31 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Neuroreport. 1995 Jul 31;6(11):1549-52.",
     "term": "hippocampus"
}